Companies / Eikonizo Therapeutics
Eikonizo Therapeutics
United States
Eikonizo Therapeutics is developing disease-modifying therapies by creating brain-penetrant and peripheral small molecules to improve the lives of people impacted by neurodegenerative, cardiorenal and other diseases.
Eikonizo Therapeutics, based in United States, has 1 investor on file, among them Mission BioCapital. Its site was last checked 13 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Mission BioCapital
52 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (90%), AI & Machine Learning (4%), E-commerce & Marketplaces (2%).
See Mission BioCapital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Eikonizo Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Mission BioCapital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/eikonizo.com/investors
# also
GET /v1/companies/eikonizo.com
GET /v1/companies/eikonizo.com/news